These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26983982)
1. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer. Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982 [TBL] [Abstract][Full Text] [Related]
2. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis. Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266 [TBL] [Abstract][Full Text] [Related]
3. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy. Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127 [TBL] [Abstract][Full Text] [Related]
4. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075 [TBL] [Abstract][Full Text] [Related]
5. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors. Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM Tumori; 2015; 101(5):585-92. PubMed ID: 26108237 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer. Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series. Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359 [TBL] [Abstract][Full Text] [Related]
8. Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy. Yamazaki H; Demizu Y; Okimoto T; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y; Oh R Strahlenther Onkol; 2017 Jul; 193(7):525-533. PubMed ID: 28424840 [TBL] [Abstract][Full Text] [Related]
10. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Re-irradiation Outcomes for Charged Particle Radiotherapy and Robotic Stereotactic Radiotherapy Using CyberKnife for Recurrent Head and Neck Cancers: A Multi-institutional Matched-cohort Analysis. Yamazaki H; Demizu Y; Okimoto T; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y Anticancer Res; 2016 Oct; 36(10):5507-5514. PubMed ID: 27798922 [TBL] [Abstract][Full Text] [Related]
12. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation. Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife. Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Kotsuma T; Yoshida K; Yoshioka Y Radiat Oncol; 2015 Oct; 10():210. PubMed ID: 26471020 [TBL] [Abstract][Full Text] [Related]
15. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer. Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582 [TBL] [Abstract][Full Text] [Related]
16. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence. Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181 [TBL] [Abstract][Full Text] [Related]
17. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512 [TBL] [Abstract][Full Text] [Related]
18. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study. Yamazaki H; Ogita M; Kodani N; Nakamura S; Inoue H; Himei K; Kotsuma T; Yoshida K; Yoshioka Y; Yamashita K; Udono H Radiother Oncol; 2013 Jun; 107(3):305-9. PubMed ID: 23751378 [TBL] [Abstract][Full Text] [Related]
19. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume. Yamazaki H; Ogita M; Himei K; Nakamura S; Yoshida K; Kotsuma T; Yamada Y; Fujiwara M; Baek S; Yoshioka Y Anticancer Res; 2014 Oct; 34(10):5755-9. PubMed ID: 25275085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]